chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warmth at the injection site; Swollen injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (Warmth at the injection site) and VACCINATION SITE SWELLING (Swollen injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Blood pressure. Concomitant products included VITAMIN B NOS, VITAMIN D NOS and BIOTIN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warmth at the injection site) and VACCINATION SITE SWELLING (Swollen injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warmth at the injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications also include Blood pressure medicine (2) Treatment information also reported  as applying Alcohol on the injection site
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L2OA) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MYALGIA (muscle ache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Feb-2021, MYALGIA (muscle ache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on the face and all over the body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on the face and all over the body) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced RASH (Rash on the face and all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (Rash on the face and all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia, Swelling
Clinical narrative: It was painfull; Swollen under arm; Redness at injection site; Fever between 100 and 103; Chlls; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (It was painfull), SWELLING (Swollen under arm), PYREXIA (Fever between 100 and 103), CHILLS (Chlls) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 26-Dec-2020. Concomitant products included VITAMIN D NOS and VITAMIN E NOS for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (Fever between 100 and 103) and CHILLS (Chlls). On 05-Feb-2021, the patient experienced PAIN (It was painfull), SWELLING (Swollen under arm) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, PAIN (It was painfull), SWELLING (Swollen under arm) and VACCINATION SITE ERYTHEMA (Redness at injection site) was resolving and PYREXIA (Fever between 100 and 103) and CHILLS (Chlls) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: high (Inconclusive) fever between 100 and 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: It was painfull; Swollen under arm; Redness at injection site; Fever between 100 and 103; Chlls; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (It was painfull), SWELLING (Swollen under arm), PYREXIA (Fever between 100 and 103), CHILLS (Chlls) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 26-Dec-2020. Concomitant products included VITAMIN D NOS and VITAMIN E NOS for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PYREXIA (Fever between 100 and 103) and CHILLS (Chlls). On 05-Feb-2021, the patient experienced PAIN (It was painfull), SWELLING (Swollen under arm) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, PAIN (It was painfull), SWELLING (Swollen under arm) and VACCINATION SITE ERYTHEMA (Redness at injection site) was resolving and PYREXIA (Fever between 100 and 103) and CHILLS (Chlls) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Body temperature: high (Inconclusive) fever between 100 and 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Headache, Myalgia, Pain
Clinical narrative: Pain; Headache; Injection site pain; Fever high of 100.5; Muscle aches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever high of 100.5) and MYALGIA (Muscle aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Pain), HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever high of 100.5), MYALGIA (Muscle aches) and FATIGUE (fatigue). At the time of the report, PAIN (Pain), HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever high of 100.5), MYALGIA (Muscle aches) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100.5 (Inconclusive) 100.5.         No Concomitant medications were provided No Treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Pain; Headache; Injection site pain; Fever high of 100.5; Muscle aches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever high of 100.5) and MYALGIA (Muscle aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Pain), HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever high of 100.5), MYALGIA (Muscle aches) and FATIGUE (fatigue). At the time of the report, PAIN (Pain), HEADACHE (Headache), VACCINATION SITE PAIN (Injection site pain), PYREXIA (Fever high of 100.5), MYALGIA (Muscle aches) and FATIGUE (fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 100.5 (Inconclusive) 100.5.         No Concomitant medications were provided No Treatment information provided
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: Cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007MZUA) for COVID-19 vaccination.     The patient's past medical history included Cold.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced NASOPHARYNGITIS (Cold). At the time of the report, NASOPHARYNGITIS (Cold) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dehydration, Diarrhoea, Head discomfort, Headache
Clinical narrative: Stomach cramping; Diarrhea; Queasy stomach; Head felt uncomfortable; headache at top of head; Dehydration; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramping), DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Queasy stomach), DEHYDRATION (Dehydration) and HEAD DISCOMFORT (Head felt uncomfortable) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DEHYDRATION (Dehydration). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramping), DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Queasy stomach), HEAD DISCOMFORT (Head felt uncomfortable) and HEADACHE (headache at top of head). The patient was treated with LOPERAMIDE HYDROCHLORIDE (LOMOTIL [LOPERAMIDE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramping), DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Queasy stomach), DEHYDRATION (Dehydration), HEAD DISCOMFORT (Head felt uncomfortable) and HEADACHE (headache at top of head) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient's stomach still felt a little queasy and went to emergency room due to dehydration.
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia
Clinical narrative: All types of digestive problems; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (All types of digestive problems) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPEPSIA (All types of digestive problems). At the time of the report, DYSPEPSIA (All types of digestive problems) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Fatigue, Heart rate, Illness
Clinical narrative: No Appetite; Felt so bad and sick; Dizzy if she got up; Laid around all day; Sore arm; Sore Body; Swollen side of the neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Sore Body), SWELLING (Swollen side of the neck), DECREASED APPETITE (No Appetite) and ILLNESS (Felt so bad and sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal, Cholesterol total abnormal NOS and Allergy NOS.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PAIN (Sore Body) and SWELLING (Swollen side of the neck). On 24-Feb-2021, the patient experienced DECREASED APPETITE (No Appetite), ILLNESS (Felt so bad and sick), DIZZINESS (Dizzy if she got up) and FATIGUE (Laid around all day). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Sore Body), SWELLING (Swollen side of the neck), DECREASED APPETITE (No Appetite), ILLNESS (Felt so bad and sick), DIZZINESS (Dizzy if she got up) and FATIGUE (Laid around all day) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Heart rate: 110 (abnormal) 110 heart rate.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient took concomitant medication as unspecified Blood Pressure, Cholesterol and Allergy medication.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021 and updated outcome of the events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Swelling
Clinical narrative: No Appetite; Felt so bad and sick; Dizzy if she got up; Laid around all day; Sore arm; Sore Body; Swollen side of the neck; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Sore Body), SWELLING (Swollen side of the neck), DECREASED APPETITE (No Appetite) and ILLNESS (Felt so bad and sick) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal, Cholesterol total abnormal NOS and Allergy NOS.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PAIN (Sore Body) and SWELLING (Swollen side of the neck). On 24-Feb-2021, the patient experienced DECREASED APPETITE (No Appetite), ILLNESS (Felt so bad and sick), DIZZINESS (Dizzy if she got up) and FATIGUE (Laid around all day). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Sore Body), SWELLING (Swollen side of the neck), DECREASED APPETITE (No Appetite), ILLNESS (Felt so bad and sick), DIZZINESS (Dizzy if she got up) and FATIGUE (Laid around all day) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Heart rate: 110 (abnormal) 110 heart rate.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient took concomitant medication as unspecified Blood Pressure, Cholesterol and Allergy medication.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021 and updated outcome of the events.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscle spasms, Paraesthesia, Vaccination site erythema
Clinical narrative: Redness and hard bump that was tender to the touch at the injection site; Redness and hard bump that was tender to the touch at the injection site; Redness and hard bump that was tender to the touch at the injection site; Muscle spasms; Tingling in her calves; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in her calves), MUSCLE SPASMS (Muscle spasms), VACCINATION SITE INDURATION (Redness and hard bump that was tender to the touch at the injection site), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness and hard bump that was tender to the touch at the injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PARAESTHESIA (Tingling in her calves), CHILLS (Chills) and HEADACHE (Headache). On 26-Jan-2021, the patient experienced MUSCLE SPASMS (Muscle spasms). On 05-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Redness and hard bump that was tender to the touch at the injection site), VACCINATION SITE ERYTHEMA (Redness and hard bump that was tender to the touch at the injection site) and VACCINATION SITE PAIN (Redness and hard bump that was tender to the touch at the injection site). On 26-Jan-2021, MUSCLE SPASMS (Muscle spasms) outcome was unknown, CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, PARAESTHESIA (Tingling in her calves), VACCINATION SITE INDURATION (Redness and hard bump that was tender to the touch at the injection site), VACCINATION SITE ERYTHEMA (Redness and hard bump that was tender to the touch at the injection site) and VACCINATION SITE PAIN (Redness and hard bump that was tender to the touch at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain
Clinical narrative: Redness and hard bump that was tender to the touch at the injection site; Redness and hard bump that was tender to the touch at the injection site; Redness and hard bump that was tender to the touch at the injection site; Muscle spasms; Tingling in her calves; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in her calves), MUSCLE SPASMS (Muscle spasms), VACCINATION SITE INDURATION (Redness and hard bump that was tender to the touch at the injection site), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (Redness and hard bump that was tender to the touch at the injection site) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PARAESTHESIA (Tingling in her calves), CHILLS (Chills) and HEADACHE (Headache). On 26-Jan-2021, the patient experienced MUSCLE SPASMS (Muscle spasms). On 05-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Redness and hard bump that was tender to the touch at the injection site), VACCINATION SITE ERYTHEMA (Redness and hard bump that was tender to the touch at the injection site) and VACCINATION SITE PAIN (Redness and hard bump that was tender to the touch at the injection site). On 26-Jan-2021, MUSCLE SPASMS (Muscle spasms) outcome was unknown, CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, PARAESTHESIA (Tingling in her calves), VACCINATION SITE INDURATION (Redness and hard bump that was tender to the touch at the injection site), VACCINATION SITE ERYTHEMA (Redness and hard bump that was tender to the touch at the injection site) and VACCINATION SITE PAIN (Redness and hard bump that was tender to the touch at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: elevated heart rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (elevated heart rate) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 08-Jan-2021, the patient experienced HEART RATE INCREASED (elevated heart rate). At the time of the report, HEART RATE INCREASED (elevated heart rate) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Heart rate: high (Inconclusive) elevated heart rate..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided Symptoms have come and gone reappearing on Jan 17th and Jan 22nd. No Treatment information provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Swelling at site of injection; tenderness on area of the injection; itchiness on the area of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE PAIN (tenderness on area of the injection) and VACCINATION SITE PRURITUS (itchiness on the area of the injection) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE PAIN (tenderness on area of the injection) and VACCINATION SITE PRURITUS (itchiness on the area of the injection). At the time of the report, VACCINATION SITE SWELLING (Swelling at site of injection), VACCINATION SITE PAIN (tenderness on area of the injection) and VACCINATION SITE PRURITUS (itchiness on the area of the injection) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  As treatment the patient was applying cold compress on the area.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia, Rash
Clinical narrative: Rash,full of rash, on face, back, stomach, and stated it's traveling to my whole body; fatigue; headache; Muscle pain; fever; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash,full of rash, on face, back, stomach, and stated it's traveling to my whole body), FATIGUE (fatigue), HEADACHE (headache), MYALGIA (Muscle pain) and PYREXIA (fever) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012020A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS and Cholesterol. Concomitant products included TRAMADOL and VITAMIN D NOS for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache), MYALGIA (Muscle pain) and PYREXIA (fever). On 07-Feb-2021, the patient experienced RASH (Rash,full of rash, on face, back, stomach, and stated it's traveling to my whole body). On 07-Feb-2021, FATIGUE (fatigue), HEADACHE (headache), MYALGIA (Muscle pain) and PYREXIA (fever) had resolved. At the time of the report, RASH (Rash,full of rash, on face, back, stomach, and stated it's traveling to my whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were provided as Cholesterol Medicine, Thyroid medicine No Treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Headache, Myalgia
Clinical narrative: Soreness; Headache; Light Headed; Difficulty Breathing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness), HEADACHE (Headache), DIZZINESS (Light Headed) and DYSPNOEA (Difficulty Breathing) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (Soreness), HEADACHE (Headache), DIZZINESS (Light Headed) and DYSPNOEA (Difficulty Breathing). At the time of the report, MYALGIA (Soreness), HEADACHE (Headache), DIZZINESS (Light Headed) and DYSPNOEA (Difficulty Breathing) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  The patient's medical history included DIAGNOSES OF CANCER TWICE as well as the DOUBLE FLU   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up report included: Patient stated that after receiving the vaccine had covid and has lost sense of smell and taste. Declined FU stating "wants to put everything behind her"
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Product dose omission issue, Rash
Clinical narrative: Did not receive second dose, per HCP; Rash all over; Very red; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not receive second dose, per HCP), RASH (Rash all over) and ERYTHEMA (Very red) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included SIMVASTATIN, TERAZOSIN, OMEPRAZOLE and IRBESARTAN for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced RASH (Rash all over) and ERYTHEMA (Very red). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive second dose, per HCP). On 04-Feb-2021, ERYTHEMA (Very red) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not receive second dose, per HCP) had resolved and RASH (Rash all over) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Added new events and outcome
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Limb discomfort, Myalgia, Pain, Vaccination site movement impairment
Clinical narrative: knot at injection site; Pain feels worse; Muscle pain in her entire arm; Can not move arm; Can not use arm; Arm burns; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can not move arm), LIMB DISCOMFORT (Can not use arm), BURNING SENSATION (Arm burns), PAIN (Pain feels worse) and VACCINATION SITE NODULE (knot at injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder NOS.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can not move arm), LIMB DISCOMFORT (Can not use arm), BURNING SENSATION (Arm burns) and MYALGIA (Muscle pain in her entire arm). On 08-Feb-2021, the patient experienced PAIN (Pain feels worse). On an unknown date, the patient experienced VACCINATION SITE NODULE (knot at injection site). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can not move arm), LIMB DISCOMFORT (Can not use arm), BURNING SENSATION (Arm burns), PAIN (Pain feels worse), VACCINATION SITE NODULE (knot at injection site) and MYALGIA (Muscle pain in her entire arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Thyroid medication
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site nodule
Clinical narrative: knot at injection site; Pain feels worse; Muscle pain in her entire arm; Can not move arm; Can not use arm; Arm burns; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Can not move arm), LIMB DISCOMFORT (Can not use arm), BURNING SENSATION (Arm burns), PAIN (Pain feels worse) and VACCINATION SITE NODULE (knot at injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder NOS.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Can not move arm), LIMB DISCOMFORT (Can not use arm), BURNING SENSATION (Arm burns) and MYALGIA (Muscle pain in her entire arm). On 08-Feb-2021, the patient experienced PAIN (Pain feels worse). On an unknown date, the patient experienced VACCINATION SITE NODULE (knot at injection site). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Can not move arm), LIMB DISCOMFORT (Can not use arm), BURNING SENSATION (Arm burns), PAIN (Pain feels worse), VACCINATION SITE NODULE (knot at injection site) and MYALGIA (Muscle pain in her entire arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included Thyroid medication
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pruritus
Clinical narrative: Generalize Body itch; Wired sensation on her lips; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Generalize Body itch) and PARAESTHESIA ORAL (Wired sensation on her lips) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PRURITUS (Generalize Body itch) and PARAESTHESIA ORAL (Wired sensation on her lips). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PRURITUS (Generalize Body itch) and PARAESTHESIA ORAL (Wired sensation on her lips) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain in extremity
Clinical narrative: Sore arm; Chills; Tiredness; This spontaneous case was reported by a dentist and describes the occurrence of PAIN IN EXTREMITY (Sore arm), CHILLS (Chills) and FATIGUE (Tiredness) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), CHILLS (Chills) and FATIGUE (Tiredness). On 08-Jan-2021, PAIN IN EXTREMITY (Sore arm), CHILLS (Chills) and FATIGUE (Tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided Treatment information provided as cold compresses
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site pruritis; Injection site swelling; Injection site red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site pruritis), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site red) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Injection site pruritis), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site red). At the time of the report, VACCINATION SITE PRURITUS (Injection site pruritis), VACCINATION SITE SWELLING (Injection site swelling) and VACCINATION SITE ERYTHEMA (Injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Headache, Injection site pain
Clinical narrative: Arm is Sore; Sluggish; chills/shivering; Lower back pain; Neck Pain; Skin was sensitive; Shaking; Sore on injection site; Extremely nausea; Headache; Joint pain/shoulder pain/kneepain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain), PAIN IN EXTREMITY (Arm is Sore), SLUGGISHNESS (Sluggish), NECK PAIN (Neck Pain) and SENSITIVE SKIN (Skin was sensitive) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLECAINIDE for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced BACK PAIN (Lower back pain), NECK PAIN (Neck Pain), SENSITIVE SKIN (Skin was sensitive), TREMOR (Shaking), INJECTION SITE PAIN (Sore on injection site), NAUSEA (Extremely nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain/shoulder pain/kneepain). On 07-Feb-2021, the patient experienced CHILLS (chills/shivering). On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is Sore) and SLUGGISHNESS (Sluggish). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Lower back pain), PAIN IN EXTREMITY (Arm is Sore), SLUGGISHNESS (Sluggish), NECK PAIN (Neck Pain), SENSITIVE SKIN (Skin was sensitive), TREMOR (Shaking), INJECTION SITE PAIN (Sore on injection site), NAUSEA (Extremely nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain/shoulder pain/kneepain) and CHILLS (chills/shivering) outcome was unknown.            12 hours after receiving the vaccine, patient experienced extremely nausea (did not vomit), headache, neck and shoulder pain, joint pain, lower back pain and knee pain. Patient also reported the skin was sensitive and had sore on injection site. Twenty four hours after second shot patient had chills, shaking and shivering. On 08Feb2021 patient's arm is very sore and patient feels a little sluggish.   Patient took Gatorade to treat symptoms.   This case was linked to MOD-2021-058085.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Pain in extremity, Sensitive skin, Sluggishness
Clinical narrative: Arm is Sore; Sluggish; chills/shivering; Lower back pain; Neck Pain; Skin was sensitive; Shaking; Sore on injection site; Extremely nausea; Headache; Joint pain/shoulder pain/kneepain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain), PAIN IN EXTREMITY (Arm is Sore), SLUGGISHNESS (Sluggish), NECK PAIN (Neck Pain) and SENSITIVE SKIN (Skin was sensitive) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLECAINIDE for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced BACK PAIN (Lower back pain), NECK PAIN (Neck Pain), SENSITIVE SKIN (Skin was sensitive), TREMOR (Shaking), INJECTION SITE PAIN (Sore on injection site), NAUSEA (Extremely nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain/shoulder pain/kneepain). On 07-Feb-2021, the patient experienced CHILLS (chills/shivering). On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is Sore) and SLUGGISHNESS (Sluggish). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Lower back pain), PAIN IN EXTREMITY (Arm is Sore), SLUGGISHNESS (Sluggish), NECK PAIN (Neck Pain), SENSITIVE SKIN (Skin was sensitive), TREMOR (Shaking), INJECTION SITE PAIN (Sore on injection site), NAUSEA (Extremely nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain/shoulder pain/kneepain) and CHILLS (chills/shivering) outcome was unknown.            12 hours after receiving the vaccine, patient experienced extremely nausea (did not vomit), headache, neck and shoulder pain, joint pain, lower back pain and knee pain. Patient also reported the skin was sensitive and had sore on injection site. Twenty four hours after second shot patient had chills, shaking and shivering. On 08Feb2021 patient's arm is very sore and patient feels a little sluggish.   Patient took Gatorade to treat symptoms.   This case was linked to MOD-2021-058085.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Arm is Sore; Sluggish; chills/shivering; Lower back pain; Neck Pain; Skin was sensitive; Shaking; Sore on injection site; Extremely nausea; Headache; Joint pain/shoulder pain/kneepain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain), PAIN IN EXTREMITY (Arm is Sore), SLUGGISHNESS (Sluggish), NECK PAIN (Neck Pain) and SENSITIVE SKIN (Skin was sensitive) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLECAINIDE for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced BACK PAIN (Lower back pain), NECK PAIN (Neck Pain), SENSITIVE SKIN (Skin was sensitive), TREMOR (Shaking), INJECTION SITE PAIN (Sore on injection site), NAUSEA (Extremely nausea), HEADACHE (Headache) and ARTHRALGIA (Joint pain/shoulder pain/kneepain). On 07-Feb-2021, the patient experienced CHILLS (chills/shivering). On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is Sore) and SLUGGISHNESS (Sluggish). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Lower back pain), PAIN IN EXTREMITY (Arm is Sore), SLUGGISHNESS (Sluggish), NECK PAIN (Neck Pain), SENSITIVE SKIN (Skin was sensitive), TREMOR (Shaking), INJECTION SITE PAIN (Sore on injection site), NAUSEA (Extremely nausea), HEADACHE (Headache), ARTHRALGIA (Joint pain/shoulder pain/kneepain) and CHILLS (chills/shivering) outcome was unknown.            12 hours after receiving the vaccine, patient experienced extremely nausea (did not vomit), headache, neck and shoulder pain, joint pain, lower back pain and knee pain. Patient also reported the skin was sensitive and had sore on injection site. Twenty four hours after second shot patient had chills, shaking and shivering. On 08Feb2021 patient's arm is very sore and patient feels a little sluggish.   Patient took Gatorade to treat symptoms.   This case was linked to MOD-2021-058085.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: 3-1/2 inch red circle 2 inches below the injection site; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE ERYTHEMA (3-1/2 inch red circle 2 inches below the injection site) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (3-1/2 inch red circle 2 inches below the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (3-1/2 inch red circle 2 inches below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Furuncle, Pruritus, Swelling
Clinical narrative: Boil/rash on her left side of her face (3 bubbles); Right side upper thigh itchy/face itchy; right side upper thigh 3 bumps/left finger 2 bumps; This spontaneous case was reported by a consumer and describes the occurrence of FURUNCLE (Boil/rash on her left side of her face (3 bubbles)), PRURITUS (Right side upper thigh itchy/face itchy) and SWELLING (right side upper thigh 3 bumps/left finger 2 bumps) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced FURUNCLE (Boil/rash on her left side of her face (3 bubbles)), PRURITUS (Right side upper thigh itchy/face itchy) and SWELLING (right side upper thigh 3 bumps/left finger 2 bumps). At the time of the report, FURUNCLE (Boil/rash on her left side of her face (3 bubbles)), PRURITUS (Right side upper thigh itchy/face itchy) and SWELLING (right side upper thigh 3 bumps/left finger 2 bumps) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: No specific follow-up information recorded.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokinesia, Pain, Vaccination site induration, Vaccination site pain
Clinical narrative: Increased pain in the same arm; Increased tightness in the same arm; Limited Range of Motion; Soreness in the arm of administration; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in the arm of administration), PAIN (Increased pain in the same arm), VACCINATION SITE INDURATION (Increased tightness in the same arm) and HYPOKINESIA (Limited Range of Motion) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness in the arm of administration). On 04-Feb-2021, the patient experienced PAIN (Increased pain in the same arm), VACCINATION SITE INDURATION (Increased tightness in the same arm) and HYPOKINESIA (Limited Range of Motion). At the time of the report, VACCINATION SITE PAIN (Soreness in the arm of administration), PAIN (Increased pain in the same arm), VACCINATION SITE INDURATION (Increased tightness in the same arm) and HYPOKINESIA (Limited Range of Motion) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.